Interestingly, 71.4% of HCC patients with AFP levels below 20 ng/mL showed loss of heterozygosity in the microsatellite regions, suggesting that this factor is an early marker of tumour development [84]. This evidence concerns the gene AFP and hepatocellular carcinoma.